Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effect

SM. Afify, A. Regner, LF. Pacios, BR. Blokhuis, SA. Jensen, FA. Redegeld, I. Pali-Schöll, K. Hufnagl, R. Bianchini, S. Guethoff, MF. Kramer, A. Fiocchi, Z. Dvorak, E. Jensen-Jarolim, F. Roth-Walter

. 2022 ; 52 (3) : 426-441. [pub] 20211203

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019256

Grantová podpora
SFB F4606-B28 Austrian Science Fund
Biomedical International R+D GmbH
Bencard Allergie GmbH

BACKGROUND: Previously, the protective farm effect was imitated using the whey protein beta-lactoglobulin (BLG) that is spiked with iron-flavonoid complexes. Here, we formulated for clinical translation a lozenge as food for special medical purposes (FSMP) using catechin-iron complexes as ligands for BLG. The lozenge was tested in vitro and in a therapeutical BALB/c mice model. METHODS: Binding of iron-catechin into BLG was confirmed by spectroscopy and docking calculations. Serum IgE binding of children allergic or tolerating milk was assessed to loaded (holo-) versus empty (apo-) BLG and for human mast cell degranulation. BLG and Bet v 1 double-sensitized mice were orally treated with the holoBLG or placebo lozenge, and immunologically analysed after systemic allergen challenge. Human PBMCs of pollen allergic subjects were flow cytometrically assessed after stimulation with apoBLG or holoBLG using catechin-iron complexes as ligands. RESULTS: One major IgE and T cell epitope were masked by catechin-iron complexes, which impaired IgE binding of milk-allergic children and degranulation of mast cells. In mice, only supplementation with the holoBLG lozenge reduced clinical reactivity to BLG and Bet v 1, promoted Tregs, and suppressed antigen presentation. In allergic subjects, stimulation of PBMCs with holoBLG led to a significant increase of intracellular iron in circulating CD14+ cells with significantly lower expression of HLADR and CD86 compared to their stimulation with apoBLG. CONCLUSION: The FSMP lozenge targeted antigen presenting cells and dampened immune activation in human immune cells and allergic mice in an antigen-non-specific manner, thereby conferring immune resilience against allergic symptoms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019256
003      
CZ-PrNML
005      
20220804135457.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cea.14050 $2 doi
035    __
$a (PubMed)34773648
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Afify, Sheriene Moussa $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria $u Laboratory Medicine and Immunology Department, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt $1 https://orcid.org/0000000320829038
245    10
$a Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effect / $c SM. Afify, A. Regner, LF. Pacios, BR. Blokhuis, SA. Jensen, FA. Redegeld, I. Pali-Schöll, K. Hufnagl, R. Bianchini, S. Guethoff, MF. Kramer, A. Fiocchi, Z. Dvorak, E. Jensen-Jarolim, F. Roth-Walter
520    9_
$a BACKGROUND: Previously, the protective farm effect was imitated using the whey protein beta-lactoglobulin (BLG) that is spiked with iron-flavonoid complexes. Here, we formulated for clinical translation a lozenge as food for special medical purposes (FSMP) using catechin-iron complexes as ligands for BLG. The lozenge was tested in vitro and in a therapeutical BALB/c mice model. METHODS: Binding of iron-catechin into BLG was confirmed by spectroscopy and docking calculations. Serum IgE binding of children allergic or tolerating milk was assessed to loaded (holo-) versus empty (apo-) BLG and for human mast cell degranulation. BLG and Bet v 1 double-sensitized mice were orally treated with the holoBLG or placebo lozenge, and immunologically analysed after systemic allergen challenge. Human PBMCs of pollen allergic subjects were flow cytometrically assessed after stimulation with apoBLG or holoBLG using catechin-iron complexes as ligands. RESULTS: One major IgE and T cell epitope were masked by catechin-iron complexes, which impaired IgE binding of milk-allergic children and degranulation of mast cells. In mice, only supplementation with the holoBLG lozenge reduced clinical reactivity to BLG and Bet v 1, promoted Tregs, and suppressed antigen presentation. In allergic subjects, stimulation of PBMCs with holoBLG led to a significant increase of intracellular iron in circulating CD14+ cells with significantly lower expression of HLADR and CD86 compared to their stimulation with apoBLG. CONCLUSION: The FSMP lozenge targeted antigen presenting cells and dampened immune activation in human immune cells and allergic mice in an antigen-non-specific manner, thereby conferring immune resilience against allergic symptoms.
650    _2
$a alergeny $7 D000485
650    _2
$a zvířata $7 D000818
650    _2
$a potravní doplňky $7 D019587
650    _2
$a farmy $7 D000072480
650    _2
$a lidé $7 D006801
650    _2
$a laktoglobuliny $x chemie $7 D007782
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    12
$a alergie na mléko $7 D016269
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Regner, Andreas $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria
700    1_
$a Pacios, Luis F $u Biotechnology Department, ETSIAAB, Center for Plant Biotechnology and Genomics, CBGP (UPM-INIA), Technical University of Madrid, Madrid, Spain $1 https://orcid.org/0000000205854289
700    1_
$a Blokhuis, Bart R $u Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
700    1_
$a Jensen, Sebastian A $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
700    1_
$a Redegeld, Frank A $u Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands $1 https://orcid.org/0000000188307960
700    1_
$a Pali-Schöll, Isabella $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000320896011
700    1_
$a Hufnagl, Karin $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $1 https://orcid.org/0000000222882468
700    1_
$a Bianchini, Rodolfo $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $1 https://orcid.org/0000000303516937
700    1_
$a Guethoff, Sonja $u Bencard Allergie GmbH, Munich, Germany $u Allergy Therapeutics, Worthing, UK
700    1_
$a Kramer, Matthias F $u Bencard Allergie GmbH, Munich, Germany $u Allergy Therapeutics, Worthing, UK $1 https://orcid.org/0000000237404733
700    1_
$a Fiocchi, Alessandro $u Childrens Hospital Bambino Gesù, Rome, Italy $1 https://orcid.org/0000000225490523 $7 xx0047154
700    1_
$a Dvorak, Zdenek $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000239383585 $7 xx0118950
700    1_
$a Jensen-Jarolim, Erika $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria $u Biomedical International R+D GmbH, Vienna, Austria $1 https://orcid.org/0000000340195765
700    1_
$a Roth-Walter, Franziska $u Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University of Vienna, Vienna, Austria $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000150059228
773    0_
$w MED00009468 $t Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology $x 1365-2222 $g Roč. 52, č. 3 (2022), s. 426-441
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34773648 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135450 $b ABA008
999    __
$a ok $b bmc $g 1822730 $s 1170499
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 52 $c 3 $d 426-441 $e 20211203 $i 1365-2222 $m Clinical and experimental allergy $n Clin Exp Allergy $x MED00009468
GRA    __
$a SFB F4606-B28 $p Austrian Science Fund
GRA    __
$p Biomedical International R+D GmbH
GRA    __
$p Bencard Allergie GmbH
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace